Skip to main content
Equibles

CITIGROUP INC

Position in RPRX — Royalty Pharma plc

CIK 831001 NEW YORK, NY
Back to RPRX Full portfolio

Position in RPRX

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$27,833,035
+$5,746,257 QoQ
Shares Held
496,398
+7.8% QoQ
Ownership
0.086%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#90
of 646 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RPRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITIGROUP INC holds $2,085,225,397 across 384 Biotechnology names. RPRX ranks #14 (1.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 706,968 $351,172,214
2 REGN
Regeneron Pharmaceuticals, Inc.
 346,637 $216,142,034
3 MRNA
Moderna, Inc.
 2,165,414 $151,643,941
4 ROIV
Roivant Sciences Ltd.
 2,225,190 $78,749,472
5 ALNY
Alnylam Pharmaceuticals, Inc.
 227,786 $68,570,419
6 INCY
Incyte Corp
 586,431 $66,477,817
7 BBIO
BridgeBio Pharma, Inc.
 864,101 $64,358,241
8 RVMD
Revolution Medicines, Inc.
 247,052 $46,267,897

All Filings in RPRX

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $27,833,035 496,398
2026-03-31 $22,086,778 460,429
2025-12-31 $14,073,729 364,227
2025-09-30 $8,941,856 253,454
2025-06-30 $13,918,280 386,297
2025-03-31 $10,393,994 333,890
2024-12-31 $9,107,961 357,035
2024-09-30 $14,951,320 528,502
2024-06-30 $15,683,266 594,739
2024-03-31 $14,329,870 471,843
2023-12-31 $9,213,321 327,993
2023-09-30 $7,576,210 279,153
2023-06-30 $7,579,653 246,573
2023-03-31 $6,195,141 171,944
2022-12-31 $4,062,813 102,804
2022-09-30 $4,953,509 123,283
2022-06-30 $4,808,954 114,390
2022-03-31 $5,997,774 153,947
2021-12-31 $4,658,184 116,893
2021-09-30 $4,718,365 130,558
2021-06-30 $4,822,268 117,645
2021-03-31 $7,211,911 165,335
2020-12-31 $3,022,018 60,380
2020-09-30 $1,591,338 37,826
2020-06-30 $9,710 200